Abstract
Despite significant progress in our understanding and treatment of metastatic cancer, nearly all metastatic cancers are incurable. In this Review, we use breast cancer as a model to highlight the limitations and inconsistencies of our existing treatment paradigms for metastatic disease. In turn, we offer a new theory of metastasis, termed “self-seeding. ” The self-seeding paradigm, well validated in mathematical, experimental and animal models, challenges the notion that cancers cells that leave a primary tumor cell, unidirectionally seed metastases in regional lymph nodes and/or distant sites. In contrast, there is mounting evidence that circulating tumor cells can move multi-directionally, seeding not only distant sites but also their tumors of origin. Here, we show that the self-seeding model may answer many of the quandaries intrinsic to understanding how cancer spreads and ultimately kills. Indeed, redirecting our research and treatment efforts within the self-seeding model may offer new possibilities for eradicating metastatic cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Norton L, Massague J (2006) Is cancer a disease of self-seeding? Nat Med 12(8):875–878
Kim MY et al (2009) Tumor self-seeding by circulating cancer cells. Cell 139(7):1315–1326
Uhr JW, Pantel K (2011) Controversies in clinical cancer dormancy. Proc Natl Acad Sci U S A 108(30):12396–400
LaBarge MA, Petersen OW, Bissell MJ (2007) Of microenvironments and mammary stem cells. Stem Cell Rev 3(2):137–146
Minn AJ et al (2007) Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A 104(16):6740–6745
Bos PD et al (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459(7249):1005–1009
Lu X et al (2009) ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev 23(16):1882–1894
Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9(4):274–284
Cenkowski M et al (2011) Tumor-to-tumor metastasis: report of a case of renal cell carcinoma metastasizing to a pancreatic endocrine neoplasm. J clin oncol off j Am Soc Clin Oncol 29(11):e303–e304
Norton L (2008) Cancer stem cells, self-seeding, and decremented exponential growth: theoretical and clinical implications. Breast Dis 29:27–36
Norton L, Simon R (1977) Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat Rep 61(7):1307–1317
Gompertz B (1832) On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. Phil Trans Roy Soc London 123:513–585
Norton L (1988) A Gompertzian model of human breast cancer growth. Cancer Res 48(24 Pt 1):7067–7071
Halsted W (1907) The results of radical operations for the cure of carcinoma of the breast. Ann Surg 46(1):1–19
Irving A (1979) Results of treating 1,178 patients with breast cancer by radical mastectomy and postoperative irradiation where metastases to axillary lymph nodes occurred. J Surg Oncol 12:137–153
Schoppmann SF et al (2004) Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240(2):306–312
Cox C et al (2006) Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann Surg Oncol 13(5):708–711
Lyman GH et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703–7720
Clarke M et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106
Shapiro DM, Fugmann RA (1957) A role for chemotherapy as an adjunct to surgery. Cancer Res 17(11):1098–1101
Fisher B (1977) Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer. Cancer 40(1 suppl):574–587
Andersson Y et al (2010) Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J Clin Oncol 28(17):2868–2873
Giuliano AE et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569–575
Wo JY et al (2011) Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer. J Clin Oncol
Hernandez-Aya LF et al (2011) Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer. J Clin Oncol
Zhang XH et al (2009) Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16(1):67–78
Whelan TJ, Olivotto I, Ackerman I, Chapman JW, Chua B, NabidA, Vallis KA, White JR, Rousseau P, Fortin A, Pierce LJ, Manchul L, Craighead P, Nolan MC, Bowen J, McCready DR, Pritchard KI, Levine MN, Parulekar W (2011) NCIC-CTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol 29
Recht A et al (1996) The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 334(21):1356–1361
Richardson WW, Bloom HJG (1957) Histological grading and prognosis in breast cancer a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11(3):359–377
Group ECO (2011) A Randomized Phase III Trial of the value of early local therapy for the intact primary tumor in patients with metastatic breast cancer E2108, 23 June 2011
Neuman HB et al (2010) Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer 116(5):1226–1233
Bafford AC et al (2009) Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Breast Cancer Res Treat 115(1):7–12
Bombonati A, Sgroi DC (2011) The molecular pathology of breast cancer progression. J Pathol 223(2):307–317
Png KJ, Yoshida M, Zhang XH, Shu W, Lee H, Rimner A, Chan TA, Comen E, Andrade VP, Kim SW, King TA, Hudis CA, Norton L, Hicks J, Massagué J, Tavazoie SF (2011) MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev 25(3):226–231
Moelans CB et al (2010) Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study. Anal Cell Pathol (Amst) 33(3):165–173
Liu H et al (2010) Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci U S A 107(42):18115–18120
Wicha MS, Liu S, Dontu G (1883) Cancer stem cells: an old idea–a paradigm shift. Cancer Res 66(4):1883–1890 (discussion 1895–1896)
Paik S et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351(27):2817–2826
van de Vijver MJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25):1999–2009
Sotiriou C, Pusztai L (2009) Gene-expression signatures in breast cancer. N Engl J Med 360(8):790–800
Alowami S et al (2003) Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 5(5):R129–R135
Boyd NF et al (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347(12):886–894
Radisky DC, Hartmann LC (2009) Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia 14(2):181–191
Ghosh K et al (2010) Independent association of lobular involution and mammographic breast density with breast cancer risk. J Natl Cancer Inst 102(22):1716–1723
Provenzano PP et al (2008) Collagen density promotes mammary tumor initiation and progression. BMC Med 6:11
Criscitiello C, Sotiriou C, Ignatiadis M (2010) Circulating tumor cells and emerging blood biomarkers in breast cancer. Curr Opin Oncol 22(6):552–558
Jones RG, Thompson CB (2009) Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev 23(5):537–548
Peggs KS et al (2006) Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. Curr Opin Immunol 18(2):206–213
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Comen, E., Norton, L. (2012). Self-Seeding in Cancer. In: Ignatiadis, M., Sotiriou, C., Pantel, K. (eds) Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer. Recent Results in Cancer Research, vol 195. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-28160-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-28160-0_2
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-28159-4
Online ISBN: 978-3-642-28160-0
eBook Packages: MedicineMedicine (R0)